BACKGROUND: Recent studies show that vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR, and a series of other angiogenic molecules, are upregulated in advanced but not low stage human neuroblastoma. Neuropilin-1 and 2 (NRP) are novel specific receptors of VEGF(165), whose role is unknown in human neuroblastoma. METHODS: Tissue biopsies of 37 children with Stage I-IV neuroblastoma were obtained, as well as biopsies of 7 normal adrenals as controls. The mRNA expression of VEGF(165) and its receptors Flt-1, KDR, NRP1, and NRP2 was evaluated by real-time reverse transcription polymerase chain reaction. NRP protein expression was detected by immunocytochemistry and Western blotting. RESULTS: VEGF(165) mRNA was upregulated in Stage III and IV and Flt-1 and KDR gene expression was increased in Stage III, while NRP1 and 2 mRNA and protein levels were higher in Stages I-IV vs. controls (P < 0.05). NRP was expressed in vascular endothelial but not tumor cells. CONCLUSIONS: These results show for the first time that human neuroblastoma expresses NRP, and that NRP co-regulates VEGF angiogenic effect in human neuroblastoma. NRP might be a sensitive angiogenic measure of VEGF systems in neuroblastoma, particularly in its early stages. Copyright 2002 American Cancer Society.
BACKGROUND: Recent studies show that vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR, and a series of other angiogenic molecules, are upregulated in advanced but not low stage humanneuroblastoma. Neuropilin-1 and 2 (NRP) are novel specific receptors of VEGF(165), whose role is unknown in humanneuroblastoma. METHODS: Tissue biopsies of 37 children with Stage I-IV neuroblastoma were obtained, as well as biopsies of 7 normal adrenals as controls. The mRNA expression of VEGF(165) and its receptors Flt-1, KDR, NRP1, and NRP2 was evaluated by real-time reverse transcription polymerase chain reaction. NRP protein expression was detected by immunocytochemistry and Western blotting. RESULTS:VEGF(165) mRNA was upregulated in Stage III and IV and Flt-1 and KDR gene expression was increased in Stage III, while NRP1 and 2 mRNA and protein levels were higher in Stages I-IV vs. controls (P < 0.05). NRP was expressed in vascular endothelial but not tumor cells. CONCLUSIONS: These results show for the first time that humanneuroblastoma expresses NRP, and that NRP co-regulates VEGF angiogenic effect in humanneuroblastoma. NRP might be a sensitive angiogenic measure of VEGF systems in neuroblastoma, particularly in its early stages. Copyright 2002 American Cancer Society.
Authors: Hua Zhang; Sarah Tam; Elizabeth S Ingham; Lisa M Mahakian; Chun-Yen Lai; Spencer K Tumbale; Tambet Teesalu; Neil E Hubbard; Alexander D Borowsky; Katherine W Ferrara Journal: Biomaterials Date: 2015-04-16 Impact factor: 12.479
Authors: Eric E Paoli; Elizabeth S Ingham; Hua Zhang; Lisa M Mahakian; Brett Z Fite; M Karen Gagnon; Sarah Tam; Azadeh Kheirolomoom; Robert D Cardiff; Katherine W Ferrara Journal: J Control Release Date: 2014-01-13 Impact factor: 9.776
Authors: Thomas L Sims; Regan F Williams; Cathy Y Ng; Shannon F Rosati; Yunyu Spence; Andrew M Davidoff Journal: Surgery Date: 2008-08 Impact factor: 3.982
Authors: Alexander A Parikh; Fan Fan; Wen Biao Liu; Syed A Ahmad; Oliver Stoeltzing; Niels Reinmuth; Diane Bielenberg; Corazon D Bucana; Michael Klagsbrun; Lee M Ellis Journal: Am J Pathol Date: 2004-06 Impact factor: 4.307